HeartSciences Inc.
HSCS
$2.89
$0.072.56%
NASDAQ
| 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | 10/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.40K | 1.90K | 4.40K | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.40K | 1.90K | 4.40K | -- | -- |
| Cost of Revenue | 1.00K | 800.00 | 1.90K | -- | -- |
| Gross Profit | 1.40K | 1.10K | 2.50K | -- | -- |
| SG&A Expenses | 1.35M | 878.10K | 993.80K | 1.34M | 786.10K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.08M | 1.88M | 1.92M | 2.37M | 1.99M |
| Operating Income | -2.07M | -1.87M | -1.92M | -2.37M | -1.99M |
| Income Before Tax | -2.35M | -2.06M | -2.09M | -2.54M | -2.08M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.35M | -2.06M | -2.09M | -2.54M | -2.08M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.35M | -2.06M | -2.09M | -2.54M | -2.08M |
| EBIT | -2.07M | -1.87M | -1.92M | -2.37M | -1.99M |
| EBITDA | -2.07M | -1.87M | -1.91M | -2.37M | -1.97M |
| EPS Basic | -0.85 | -1.58 | -1.96 | -2.57 | -2.27 |
| Normalized Basic EPS | -0.53 | -0.99 | -1.22 | -1.61 | -1.42 |
| EPS Diluted | -0.85 | -1.58 | -1.96 | -2.57 | -2.27 |
| Normalized Diluted EPS | -0.53 | -0.99 | -1.22 | -1.61 | -1.42 |
| Average Basic Shares Outstanding | 2.78M | 1.30M | 1.07M | 986.10K | 917.40K |
| Average Diluted Shares Outstanding | 2.78M | 1.30M | 1.07M | 986.10K | 917.40K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |